1. The impact of Centers for Medicare and Medicaid Services high-risk criteria on outcome after carotid endarterectomy and carotid artery stenting in the SVS Vascular Registry
- Author
-
Christopher T. Kenwood, Jeffrey Jim, Flora S. Siami, Rodney A. White, Ellen D. Dillavou, Marc L. Schermerhorn, Margriet Fokkema, and Philip P. Goodney
- Subjects
Adult ,Carotid Artery Diseases ,Male ,medicine.medical_specialty ,Time Factors ,Adolescent ,medicine.medical_treatment ,Myocardial Infarction ,Carotid endarterectomy ,Asymptomatic ,Risk Assessment ,Article ,Centers for Medicare and Medicaid Services, U.S ,Decision Support Techniques ,Young Adult ,Risk Factors ,Internal medicine ,Angioplasty ,medicine ,Odds Ratio ,Humans ,Myocardial infarction ,Registries ,Stroke ,Endarterectomy ,Aged ,Aged, 80 and over ,Endarterectomy, Carotid ,Chi-Square Distribution ,business.industry ,Patient Selection ,Odds ratio ,Middle Aged ,medicine.disease ,United States ,Surgery ,Treatment Outcome ,Ischemic Attack, Transient ,Multivariate Analysis ,Cardiology ,Female ,Stents ,medicine.symptom ,business ,Cardiology and Cardiovascular Medicine ,Mace - Abstract
ObjectiveThe Centers for Medicare and Medicaid Services (CMS) require high-risk (HR) criteria for carotid artery stenting (CAS) reimbursement. The impact of these criteria on outcomes after carotid endarterectomy (CEA) and CAS remains uncertain. Additionally, if these HR criteria are associated with more adverse events after CAS, then existing comparative effectiveness analysis of CEA vs CAS may be biased. We sought to elucidate this using data from the SVS Vascular Registry.MethodsWe analyzed 10,107 patients undergoing CEA (6370) and CAS (3737), stratified by CMS HR criteria. The primary endpoint was composite death, stroke, and myocardial infarction (MI) (major adverse cardiovascular event [MACE]) at 30 days. We compared baseline characteristics and outcomes using univariate and multivariable analyses.ResultsCAS patients were more likely to have preoperative stroke (26% vs 21%) or transient ischemic attack (23% vs 19%) than CEA. Although age ≥80 years was similar, CAS patients were more likely to have all other HR criteria. For CEA, HR patients had higher MACEs than normal risk in both symptomatic (7.3% vs 4.6%; P < .01) and asymptomatic patients (5% vs 2.2%; P < .0001). For CAS, HR status was not associated with a significant increase in MACE for symptomatic (9.1% vs 6.2%; P = .24) or asymptomatic patients (5.4% vs 4.2%; P = .61). All CAS patients had MACE rates similar to HR CEA. After multivariable risk adjustment, CAS had higher rates than CEA for MACE (odds ratio [OR], 1.2; 95% confidence interval [CI], 1.0-1.5), death (OR, 1.5; 95% CI, 1.0-2.2), and stroke (OR, 1.3; 95% CI,1.0-1.7), whereas there was no difference in MI (OR, 0.8; 95% CI, 0.6-1.3). Among CEA patients, age ≥80 (OR, 1.4; 95% CI, 1.02-1.8), congestive heart failure (OR, 1.7; 95% CI, 1.03-2.8), EF
- Full Text
- View/download PDF